o n w i t h SLT-specific DNA probes. S e r i a l serum samples from 1 2 p t s and a p p r o p r i a t e c o n t r o l s were s t u d i e d f o r SLT I and I1 n e u t r a l i z i n g a n t i b o d i e s (NAB) and f o r h e m a g g l u t i n a t i n g a n t i b od i e s (HA) u s i n g e r y t h o c y t e s c o a t e d with p u r i f i e d LPS from E . c o l i 0157:H7 and o t h e r s e r o v a r s . SLT a s s o c i a t i o n was demonstrated i n 13/22 c h i l d r e n 159%); E.coli i s o l a t e s (n=6 p t s ) included serogroups 026, 055, 0111 and 0157; f e c a l SLT a l o n e was p r e s e n t i n 7 a d d i t i o n a l c a s e s . 4 p t s developed r i s i n g NAB-titers a g a i n s t SLT I o r 11; 9 p t s (75%) p r e s e n t e d w i t h h i g h LPS-0157-HA a t t h e time o f t h e d i a g n o s i s o f HUS t h a t r a p i d l y d e c l i n e d d u r i n g convalescence.
U n i v e r s i t y o f Hamburg, 0-2000 Hamburg 20, FRG. P a t i e n t s with c l a s s i c a l HUS (n=22; median age 2;2 y r s ) were p r o s p e c t i v e l y s t u d i e d a t o u r i n s t i t u t i o n s i n c e 1986. SLT-association was e s t a b l i s h e d by c y t o t o r i c i t y a s s a y s o f f e c a l f i l t r a t e s , b a c t e r i a l i s o l a t i o n o r colony-blot-hybridizati-
o n w i t h SLT-specific DNA probes. S e r i a l serum samples from 1 2 p t s and a p p r o p r i a t e c o n t r o l s were s t u d i e d f o r SLT I and I1 n e u t r a l i z i n g a n t i b o d i e s (NAB) and f o r h e m a g g l u t i n a t i n g a n t i b od i e s (HA) u s i n g e r y t h o c y t e s c o a t e d with p u r i f i e d LPS from E . c o l i 0157:H7 and o t h e r s e r o v a r s . SLT a s s o c i a t i o n was demonstrated i n 13/22 c h i l d r e n 159%); E.coli i s o l a t e s (n=6 p t s ) included serogroups 026, 055, 0111 and 0157; f e c a l SLT a l o n e was p r e s e n t i n 7 a d d i t i o n a l c a s e s . 4 p t s developed r i s i n g NAB-titers a g a i n s t SLT I o r 11; 9 p t s (75%) p r e s e n t e d w i t h h i g h LPS-0157-HA a t t h e time o f t h e d i a g n o s i s o f HUS t h a t r a p i d l y d e c l i n e d d u r i n g convalescence.
Thus i n N o r t h e r n Germany a n a s s o c i a t i o n o f t h e c l a s s i c a l HUS w i t h in-vivo SLT p r o d u c t i o n h a s been confirmed. D e t e c t i o n o f LPS-0157-AB a p p e a r s t o be a new, v a l u a b l e s e r o l o g i c a l marker f o r t h i s subgroup o f HUS. F u r t h e r s t u d i e s a r e needed t o e l u c i d a t e a p o s s i b l e p r o t e c t i v e o r pathogenic r o l e o f SLT-and LPS-specific AB. Sauer. Sophia Children's Hosp., Rotterdam. The Netherlands. Furmulas specially designed for preterm infants contain up to 50% MCT because of their almost complete absorption. The effects of ,MCT(C8 and C10) on mineral absorption were studied in infants receiving formula (Nutricia,Holland) with 5%(LCT group) or 40C,(MCT group) of fat as MCT, providing 80 mg P-, I52 mg Ca-and 120 kcal/kg.d,+ 600 IU/day vit D. 72 hr balance studies were performed at 4 weeks of age. Values:mean 2 lsd or median with interquartile range. Plasma levels (MCT vs LCT) of Ca(2.42 0.1 vs 2.4f 0.1 mmol/L). P(2.2f 0.3 vs 2.320.2 mmol/L) and Alkaline Phosphatase ( 2 7 3 2 7 4~s 295f43 IU/L) were in the normal range.
NITROGEN AND FAT DEPOSITION IN PRETERhI INFANTS FED
MCT on regular dialysis therapy (II). 34 after uanrplanution (Ul):variation of EPO concentration in children with these various slags of chronic renal failure (CRF) were compved to 40 conuols with nomcnal ancmia(1V)and healthy conuols ( V) .
-0: relative EPO deficiency could be detected in I and less after renal mansplanration , an absolute deficiency wrr found on regular dialyris.An inverse linear melation between EPO levels and hemoglobin in IV Q E C W C~ however in Il the rise of EPO war LuuEciat mmpared to 1V.h our swdy we could demomuate successfully a feedback mechanism between EPO and oxygen supply (low hemoglobin).
-The ~ntmelationships between EPO and Hb in memicchildren on regular dialysis indicates an EPO deficiency and lack of a regulatory feedbafk mechanism duc to CRF, possibly an inhibition of erythropoiesis by uremic toxins.We emphasize rmal anemia could n t h e s i s of hu'man haemo lobin i s d i r e c t e d by a-8-6 -%7-and A1ay-genes. ~! e switch from f e t a l 'to 'aduit erythropoiesis includes a g e n e t i c a l l y controlled sup r e s s i o n of t h e I-and a c t i v a t i o n of t h e 8-and 6-chain svnthesis. f h e two I-aenes a r e not equally i n a c t i v a t e d . In animals e i t e r n a l influences'on t h e switch could be demonstrated, but no influence of e x t r a u t e r i n e (EU) l i f e on t h e switch i n human newborns could be c l e a r l y demonstrated. The lona h a l f l i f e of red c e l l s h a m~e r s t h e d e t e c t i o n o f s u b t l e influences on t h e switch bv cornnarino i h e concpntrationc nf HhA HhF and i~A,--we-.st;di -ther;foifortrhe az-n;novo -s-y.n-t-ie--i-s--9-f-a--; pI;.' A,,";l and Yy chains by measuring t h e incorporation of H-Leucine i n t o r e t i c u l o c y t e s and subseauent s e~a r a t i o n of t h e qlobin chains bv HPLC. 228 s i n o l e measurements'were obtained from 8 8 newborns l o e s t i t i o n a l age 26.3 t o 42.1 weeks) a t t h e age of 0 t o 116 days; 16'6abies were studied lon i t u d i n a l l y . The r e s u l t s show t h a t t h e switch 7-->8 i s governed by t\e biological age (BA -i n t r a u t e r i n e + EU age). A s i gn i f i c a n t a c c e l e r a t i o n of t h e switch by EU l i f e could be demonstrated: age 26.3 t o 42.1 weeks) a t t h e age of 0 t o 116 days; 16'6abies were studied lon i t u d i n a l l y . The r e s u l t s show t h a t t h e switch 7-->8 i s governed by t\e biological age (BA -i n t r a u t e r i n e n i f i c a n t a c c e l e r a t i o n of t h e switch by 1.The B A when 16 babies reached 50% (33%) of t h e f u l l switch was not constant but c o r r e l a t e d with GA: ~c d . 0 1 '(pt0.05). 2. When 31 babies were studied a t a BA of 40 t o 43 weeks, a s i g n i f i c a n t (pt0.02) accel e r a t i o n o f t h e switch was found in those with an EU aqe of 6 t o 7 weeks (47%?21%, n-14) when compared t o babies of 1 week o r J e s s of EU age (37%i25%, n-14) . No comparab1.e changes o f t h e A"7/ IYyp a t t e r n was observed during t h e observation time of 26 t o 43 weeks.
Conclusion: 7-->p-fyittlj is,accelerated by f a c t o r s of EU 1 i f e . I n a c t i - Alpha-I antitrypsin (AAT) deficiency is an hereditary metabolic disorder which predisposes affected individuals to juvenile liver disease and to pulmonary emphysema towards the third or fourth decade of life. Since prevention and ueaunent of this pulmonary complication is at present perfectly feasible, we have carried out a pilot study of neonatal screening for AAT deficiency in order to determine the incidence of this deficiency in Spain and to evaluate the parents' reactions on k i n g told of this metabolic disorder .
Fifteen thousand four hundred spanish newborn infants were screened for AAT deficiency. The study was carried out using the eluate from dried blood samples provided by the Cantabria Univers~ly and the Basque Counuy Health Service Units for the detection of metabolic disorders. The screening test was based on a semiquantitative elecuoimmunoassay for AAT together with wansferrin . For all cases suspected of AAT deficiency, the Pi phenotype was determined.
With the screening test. 58 suspect cases were detected. Of these. the phenotype study showed 32 AAT deficient cases (8 Pi Z and 24 Pi SZ) representing a global incidence of 2.08tO.72 per thousand. In 4 Pi Z cases there was clinical and laboratory evidence of liver disease. The parents of the AATdeficient children were informed of the potentially harmfull effect of tobacco smoke on the child. Their reaction towards this information was positive.
Bearing in mind the high incidence of AAT-deficiency, and the existing preventive and therapeutic measures for pulmonary emphysema in AAT-deficient cases, mass-screening for this deficiency may be advisable. This screening could bc considerably facilitated by recently developed genome analysis techniques.
